Daily FNArena News

A glance through the latest expert views and predictions about commodities: China stimulus supporting iron ore, copper; near-term risk for zinc; lithium prices to fall further

Tim Boreham highlights how PYC Therapeutics’ gene therapy can address a plethora of genetic afflictions

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Today’s idea is on Orica

Michael Gable of Fairmont Equities notes that after a period of oil price-related weakness, Woodside Energy has gapped up in a clear reversal

In FNArena’s final instalment for the FY23 ESG reporting season, we round up analysts’ observations on of psychosocial safety metrics; reconciliation action plans; modern slavery reporting and gender diversity

Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments

We’re going macro this week as some analysts tip rate cuts as early as March, before going green: capital costs are falling for green manufacturers and decarbonisers; plus lots more.

The ASX doesn’t offer many choices to invest in Tier-1 gold mining. New research highlights Northern Star Resources as a scarce investment opportunity